Evidence map›Paper›PMID 33804198›Full record

ReviewInternational journal of molecular sciences2021

Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.

Elena Gammella, Margherita Correnti, Gaetano Cairo, Stefania Recalcati

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Molecular mechanisms of ferroptosis and its effects on bladder cancer.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Heme Oxygenase-1 (Journal of fungi (Basel, Switzerland) · 2022
    Article
  17. Ferroptosis and Autoimmune Diseases.Frontiers in immunology · 2022
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elena GammellaDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milano, Italy.
Margherita CorrentiDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milano, Italy.
Gaetano CairoDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milano, Italy.
Stefania RecalcatiDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milano, Italy.
University of Milan · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca OREYFZH_002
6 · The paper itself

Abstract

Body iron levels are regulated by hepcidin, a liver-derived peptide that exerts its function by controlling the presence of ferroportin (FPN), the sole cellular iron exporter, on the cell surface. Hepcidin binding leads to FPN internalization and degradation, thereby inhibiting iron release, in particular from iron-absorbing duodenal cells and macrophages involved in iron recycling. Disruption in this regulatory mechanism results in a variety of disorders associated with iron-deficiency or overload. In recent years, increasing evidence has emerged to indicate that, in addition to its role in systemic iron metabolism, FPN may play an important function in local iron control, such that its dysregulation may lead to tissue damage despite unaltered systemic iron homeostasis. In this review, we focus on recent discoveries to discuss the role of FPN-mediated iron export in the microenvironment under both physiological and pathological conditions.

Indexed as

Cation Transport ProteinsCellular MicroenvironmentFerroportinHepcidinsHomeostasisHumansIronLiverMacrophagesProtein BindingCation Transport ProteinsFerroportinHepcidinsIronferroportinironmacrophagesmicroenvironment

Identifiers

PMID33804198
PMCPMC7999357
OpenAlexW3137077818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.